Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex

Abstract

The tumour suppressor gene RASSF1A is frequently silenced in lung cancer and other sporadic tumours as a result of hypermethylation of a CpG island in its promoter1,2,3,4,5,6. However, the precise mechanism by which RASSF1A functions in cell cycle regulation and tumour suppression has remained unknown. Here we show that RASSF1A regulates the stability of mitotic cyclins and the timing of mitotic progression. RASSF1A localizes to microtubules during interphase and to centrosomes and the spindle during mitosis. The overexpression of RASSF1A induced stabilization of mitotic cyclins and mitotic arrest at prometaphase. RASSF1A interacts with Cdc20, an activator of the anaphase-promoting complex (APC), resulting in the inhibition of APC activity. Although RASSF1A does not contribute to either the Mad2-dependent spindle assembly checkpoint or the function of Emi1 (ref. 1), depletion of RASSF1A by RNA interference accelerated the mitotic cyclin degradation and mitotic progression as a result of premature APC activation. It also caused a cell division defect characterized by centrosome abnormalities and multipolar spindles. These findings implicate RASSF1A in the regulation of both APC–Cdc20 activity and mitotic progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: RASFF1A localizes to microtubules and induces mitotic arrest at prometaphase.
Figure 2: RASSF1A interacts with Cdc20.
Figure 3: RASSF1A regulates APC–Cdc20 activity.
Figure 4: RASSF1A inhibits APC–Cdc20 independently of the spindle assembly checkpoint or Emi1.
Figure 5: Loss of RASSF1A results in acceleration of mitotic progression and in mitotic abnormalities.

Similar content being viewed by others

References

  1. Dammann, R. et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genet. 25, 315–319 (2000).

    Article  CAS  Google Scholar 

  2. Astuti, D. et al. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 20, 7573–7577 (2001).

    Article  CAS  Google Scholar 

  3. Burbee, D.G. et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93, 691–699 (2001).

    Article  CAS  Google Scholar 

  4. Dammann, R., Takahashi, T. & Pfeifer, G.P. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 20, 3563–3567 (2001).

    Article  CAS  Google Scholar 

  5. Dreijerink, K. et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl Acad. Sci. USA 98, 7504–7509 (2001).

    Article  CAS  Google Scholar 

  6. Lo, K.W. et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res. 61, 3877–3881 (2001).

    CAS  PubMed  Google Scholar 

  7. King, R.W., Deshaies, R.J., Peters, J.M. & Kirschner, M.W. How proteolysis drives the cell cycle. Science 274, 1652–1659 (1996).

    Article  CAS  Google Scholar 

  8. Zachariae, W. & Nasmyth, K. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev. 13, 2039–2058 (1999).

    Article  CAS  Google Scholar 

  9. Jallepalli, P.V. & Lengauer, C. Chromosome segregation and cancer: cutting through the mystery. Nature Rev. Cancer 1, 109–117 (2001).

    Article  CAS  Google Scholar 

  10. Peters, J.M. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9, 931–943 (2002).

    Article  CAS  Google Scholar 

  11. Visintin, R., Prinz, S. & Amon, A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278, 460–463 (1997).

    Article  CAS  Google Scholar 

  12. Reimann, J.D., Gardner, B.E., Margottin-Goguet, F. & Jackson, P.K. Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. Genes Dev. 15, 3278–3285 (2001).

    Article  CAS  Google Scholar 

  13. Reimann, J.D. et al. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105, 645–655 (2001).

    Article  CAS  Google Scholar 

  14. Hsu, J.Y., Reimann, J.D., Sorensen, C.S., Lukas, J. & Jackson, P.K. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1). Nature Cell Biol. 4, 358–366 (2002).

    Article  CAS  Google Scholar 

  15. Vos, M.D., Ellis, C.A., Bell, A., Birrer, M.J. & Clark, G.J. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275, 35669–35672 (2000).

    Article  CAS  Google Scholar 

  16. Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R. & White, M.A. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22, 4309–4318 (2002).

    Article  CAS  Google Scholar 

  17. Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813–826 (2003).

    Article  CAS  Google Scholar 

  18. Zhang, Y. & Lees, E. Identification of an overlapping binding domain on Cdc20 for Mad2 and anaphase-promoting complex: model for spindle checkpoint regulation. Mol. Cell. Biol. 21, 5190–5199 (2001).

    Article  CAS  Google Scholar 

  19. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553 (2002).

    Article  CAS  Google Scholar 

  20. Luo, X., Tang, Z., Rizo, J. & Yu, H. The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding to either Mad1 or Cdc20. Mol. Cell 9, 59–71 (2002).

    Article  Google Scholar 

  21. Martin-Lluesma, S., Stucke, V.M. & Nigg, E.A. Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297, 2267–2270 (2002).

    Article  CAS  Google Scholar 

  22. Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799–812 (2003).

    Article  CAS  Google Scholar 

  23. Raff, J.W., Jeffers, K. & Huang, J.Y. The roles of Fzy/Cdc20 and Fzr/Cdh1 in regulating the destruction of cyclin B in space and time. J. Cell Biol. 157, 1139–1149 (2002).

    Article  CAS  Google Scholar 

  24. Cahill, D.P. et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303 (1998).

    Article  CAS  Google Scholar 

  25. Fodde, R. et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nature Cell Biol. 3, 433–438 (2001).

    Article  CAS  Google Scholar 

  26. Kaplan, K.B. et al. A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nature Cell Biol. 3, 429–432 (2001).

    Article  CAS  Google Scholar 

  27. Jallepalli, P.V. et al. Securin is required for chromosomal stability in human cells. Cell 105, 445–457 (2001).

    Article  CAS  Google Scholar 

  28. Lim, D.S. et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404, 613–617 (2000).

    Article  CAS  Google Scholar 

  29. Fang, G., Yu, H. & Kirschner, M.W. The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev. 12, 1871–1883 (1998).

    Article  CAS  Google Scholar 

  30. Buschmann, T., Fuchs, S.Y., Lee, C.G., Pan, Z.Q. & Ronai, Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101, 753–762 (2000).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank M. White and C. H. Lee for RASSF1A and Cdc20 cDNAs, respectively, and B. S. Suh for comments on the manuscript. This work was supported by grants from the 21st Century Frontier Functional Human Genome Project of KISTEP (Ministry of Science and Technology of Korea) and the Biomedical Research Program of KISTEP to D.-S.L., by a grant from the National Creative Research Program of KISTEP to E.-J.C, and by a grant from the Korea Health 21 R&D Project (02-PJ-PG10-20802-0012) to H.K. D.-S.L. was also supported by a grant from the Korea National Cancer Center Control Program (0320370-1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dae-Sik Lim.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary figures

Supplementary Information, Fig. S1 (PDF 282 kb)

Supplementary Information, Fig. S2

Supplementary Information, Fig. S3

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, M., Song, S., Ayad, N. et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex. Nat Cell Biol 6, 129–137 (2004). https://doi.org/10.1038/ncb1091

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb1091

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing